01 — Founder Perspective
In the founder's words.
Draft — pending founder approval
We had built the whole thing. Encrypted case discussions, verified profiles, referrals — everything a doctor would need. And then it sat there, because a network with nobody in it gives a doctor no reason to open it twice.
First500days took the launch itself as the problem to solve: the go-to-market strategy, the community of doctors, the brand presence, and the users on the app.
The product had been finished for a while. It only became real when there were other doctors inside it.
02 — Executive Summary
The product was finished. That was the easy part.
StethoLink is a doctor-exclusive digital ecosystem: encrypted case discussions, secure referrals, verified doctor profiles and clinical tools, built for medical professionals and closed to everyone else.
When First500days was engaged, all of that already existed. The platform was built and ready to launch. What it did not have was a single reason for the first doctor to stay on it — no users, no community, and no launch strategy for getting either.
That is the hardest position a network product can be in. A social platform for doctors is worth precisely nothing to doctor number one, and only becomes worth something around doctor number several hundred. The build is finished and the business has still not started.
First500days worked on that gap for six months: the product go-to-market strategy, the doctor community, the brand presence on Instagram and LinkedIn, and user acquisition onto the app. StethoLink now has 500+ doctors in its community and 1,000+ users on the platform.
03 — The Venture
A doctor's professional network shrinks the day they leave medical college.
Medicine is a collaborative profession practised in isolation. A doctor qualifies surrounded by peers, then spends a career in one hospital or one clinic, referring to the handful of specialists they happen to know and second-guessing the cases that fall outside their own speciality. The general professional networks are no use here: a doctor cannot discuss a case in public, and cannot tell a verified colleague from a stranger.
StethoLink is built around that constraint rather than in spite of it. It is closed to non-doctors, its members are verified, its case discussions are encrypted, and its referrals go to named practitioners rather than into a search box.
Which creates the specific problem this engagement was hired to solve. Every one of those features — discussion, referral, collaboration — requires other doctors to already be there. The product cannot demonstrate its own value until the community exists, and the community will not form because the product exists.
The build was never the bottleneck. The community was — and a community is the one thing a product cannot ship with.
What was already built: the feed, referrals and verified profiles that only work once other doctors are present.
04 — Where They Started
Everything except the people.
Most of the ventures in this portfolio arrived missing a product. StethoLink arrived missing the only thing a product cannot contain.
Already in place
- Product
- Built and ready to launch
- Founder
- A practising doctor building for his own profession
Missing
- Go-to-market
- Product launch strategy not defined
- Users
- None on the app
- Community
- No doctor network assembled
- Online presence
- No brand presence to launch behind
There is a particular kind of stall that follows a finished build. The hard, expensive, visible work is done; the founder is exhausted and the thing does not appear to be doing anything. What is actually missing is a second discipline entirely.
05 — The Challenge & Our Response
One problem: a product with no users.
Simple to state, and the hardest kind to solve — because in a network product the answer is never a feature.
Go-to-market & branding
The product was ready and nobody was on it. A doctor-exclusive network has no consumer flywheel to fall back on — it cannot be seeded with casual users, and every member has to be a verified professional who chooses to spend scarce time there.
We worked with the founder to build the product go-to-market strategy, then executed it across four fronts: assembling the doctor community, establishing the brand presence on Instagram and LinkedIn, and acquiring users onto the app.
On scope: this engagement was strategy and go-to-market. The StethoLink platform was built by the client before First500days was engaged — nothing on this page claims the product as our work. What we were hired for was the distance between a finished build and a used one.
06 — What We Did
Four workstreams, one objective: put doctors inside it.
Launch strategy
The product go-to-market plan, built with the founder — who to reach first, with what argument, and in what order.
Doctor community
Assembling the 500+ verified doctors who make the platform's features work at all.
Brand presence
Building the presence on Instagram and LinkedIn — the two places a doctor checks before trusting a new platform.
User acquisition
Performance marketing to bring 1,000+ users onto the app behind the community and the brand.
The order was the strategy. Community before acquisition, because a doctor who downloads an empty app does not come back and cannot be re-acquired cheaply. Brand before both, because a professional deciding whether to put case discussions on an unfamiliar platform looks it up first — and an absent brand is an answer in itself.
07 — The Content Engine
Speaking to doctors, in the language of the job.
The content had one audience and one test: would a working doctor recognise themselves in it? That ruled out product marketing and ruled in the parts of medical life nobody outside it talks about.
@stetholink
Professional isolation, the shrinking network after medical college, the junior doctor's day, and the argument for a doctors-only space — published as short film, carousel and news-desk formats rather than feature announcements.
The content output built during the engagement, on Instagram and LinkedIn.
On numbers: no follower or view counts are claimed for these channels. The verified outcomes of this engagement are the 500+ doctor community and the 1,000+ users on the app; the social channels are shown as the work produced, not as an audience figure.
08 — Business Outcomes
Where the venture stands today.
StethoLink went from a built platform with no users to a live network with a doctor community inside it and an audience that knows the name. The features that were unusable at zero members — case discussion, referral, collaboration — now have the density they were designed for.
No revenue, retention, engagement or follower figures are claimed on this page, and the platform build is not claimed as our work. The verified outcomes of this engagement are the go-to-market strategy, the 500+ doctor community and the 1,000+ users, stated as of April 2026.
09 — Before → After
Six months of difference.
10 — The Lesson
What this proves for anyone who has already built the thing.
StethoLink is the only venture in this portfolio that arrived with a finished product — and it was no closer to being a business than the ones that arrived with nothing.
Shipping is not launching
A completed build feels like the finish line and is closer to a starting one. The skills that get a product made and the skills that get it used are different disciplines, and founders rarely have both.
For a network, the community is the product
Every feature on StethoLink depends on other doctors being present. Until they were, the platform was a demonstration. Seeding the first 500 was not marketing around the product — it was the last unbuilt part of it.
Professionals check before they trust
A doctor deciding whether to put patient cases on an unfamiliar platform will look it up first. Brand presence is not vanity in a category like this; it is the due-diligence trail that makes signing up defensible.
The hardest thing to build into a network product is the one thing you cannot write: other people already being there.
Every founder starts at zero — the first 500 days decide what you are standing on at the end of them.